The Common Polymorphism of Apolipoprotein E: Geographical Aspects and New Pathophysiological Relations

Abstract Apolipoprotein E (apoE) has important functions in systemic and local lipid transport, but also has other functions. The gene (APOE) shows a common polymorphism with three alleles – APOE*2, APOE*3, and APOE*4. Their frequencies vary substantially around the world, but APOE*3 is the most common almost everywhere and is often considered to be the ancestral or “wild-type” allele for that reason. However, there are several arguments for APOE*4 being the ancestral allele. But then, why has APOE*3 become so frequent? And why has APOE*4 not become extinct? The proportion of APOE*4 carriers increases from only 10–15% in southern Europe to 40–50% in the north. The gradient may be a trace of the demic expansion of agriculture that began about 10,000 years ago, but it may also reflect the possibility that APOE*4 carriers are less likely to develop vitamin D deficiency. The common APOE polymorphism is associated with varying risk of cardiovascular disease and Alzheimer's disease, but other interesting aspects may emerge in the future.

[1]  P. Vestergaard,et al.  Regional and Hormone‐Dependent Effects of Apolipoprotein E Genotype on Changes in Bone Mineral in Perimenopausal Women * , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  E. Bowman,et al.  Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk , 2000, Molecular carcinogenesis.

[3]  E. Faragher,et al.  Apolipoprotein E‐ϵ4 protects against severe liver disease caused by hepatitis C virus , 2002 .

[4]  J. Chapman,et al.  Preliminary Observations on APOE ϵ4 Allele and Progression of Disability in Multiple Sclerosis , 1999 .

[5]  J. Vaupel,et al.  Estimation of apolipoprotein E genotype‐specific relative mortality risks from the distribution of genotypes in centenarians and middle‐aged men: Apolipoprotein E gene is a “frailty gene,” not a “longevity gene” , 2000, Genetic epidemiology.

[6]  Jonathan D. Smith Apolipoprotein E4: an allele associated with many diseases , 2000, Annals of medicine.

[7]  G. Siest,et al.  Human Apolipoprotein E concentration in response to diseases and therapeutic treatments , 2002 .

[8]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[9]  A. Piazza,et al.  Human Genomic Diversity in Europe: A Summary of Recent Research and Prospects for the Future , 1993, European journal of human genetics : EJHG.

[10]  G. Siest,et al.  Apolipoprotein E Polymorphisms and Concentration in Chronic Diseases and Drug Responses , 2000, Clinical chemistry and laboratory medicine.

[11]  W. Strittmatter,et al.  Molecular biology of apolipoprotein E , 2002, Current opinion in lipidology.

[12]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[13]  E. Boerwinkle,et al.  Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. , 2000, Genome research.

[14]  Caleb E. Finch,et al.  The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆ , 1999, Neurobiology of Aging.

[15]  Y. Kesäniemi,et al.  Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? , 1996, Gastroenterology.

[16]  R. Mahley,et al.  Is ϵ4 the ancestral human apoE allele? , 1999, Neurobiology of Aging.

[17]  E. Boerwinkle,et al.  Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. , 2000, American journal of human genetics.

[18]  P. de Knijff,et al.  Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels , 1994, Human mutation.

[19]  P. Froom,et al.  Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injury , 1999, Neurology.

[20]  O. Faergeman,et al.  The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study. , 2000, Circulation.

[21]  L. U. Gerdes,et al.  Are men carrying the apolipoprotein ε4- or ε2 allele less fertile than ε3ε3 genotypes? , 1996, Human Genetics.